- Gastrointestinal
Name | No. | Patient Profile | Purpose |
---|---|---|---|
MK3475-811 (KEYNOTE 811) | 18-12 | Cancer of the oesophagus or gastro-oesophageal junction which has spread (metastasised). |
To compare survival between the two groups – those treated with Trastuzumab, chemotherapy and Pembrolizumab and those treated with Trastuzumab, chemotherapy and placebo. |